Alumni Ventures

Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company founded in 2017 that specializes in developing and commercializing a wearable microfluidic sensing platform. This innovative technology analyzes small droplets of sweat directly from the skin to provide insights into health, hydration, and athletic performance. The platform is designed to measure various biomarkers, including proteomics and inflammatory markers, allowing for personalized management of health and nutrition. Epicore's approach leverages over two decades of research in microfluidics and soft materials conducted by leading experts at Northwestern University. By offering a non-invasive and cost-effective solution, Epicore aims to enhance athletic performance and improve overall health monitoring for users.

Lōvu Health is a digital maternal health platform that offers services to care for mother and baby from conception to postpartum.

Andromeda Surgical is a developer of autonomous robots designed to enhance the consistency, accuracy, and efficiency of surgical procedures. The company's open platform focuses on urologic procedures that have demonstrated superior outcomes but face challenges in widespread adoption due to technical complexities. By addressing these difficulties, Andromeda Surgical aims to empower surgeons to perform various procedures at a level typically achieved only by experts, thereby improving patient care and surgical success rates.

CytoVale, Inc. is a medical technology company based in San Francisco, California, established in 2012. The company specializes in developing biomarkers that leverage the mechanical properties of individual cells, a field known as mechanomics. By utilizing microfluidics technology, CytoVale can efficiently route and physically probe single cells to measure multiple biomarkers simultaneously. This innovative approach aims to enhance early detection of immune-mediated diseases, particularly sepsis, thereby improving patient outcomes and reducing treatment costs. CytoVale's integration of cell mechanics with machine learning positions it at the forefront of revolutionizing diagnostic practices in healthcare.

Magnetic Insight, Inc. specializes in magnetic particle imaging (MPI), an innovative imaging technology that utilizes iron oxide nanoparticle tracers and time-varying magnetic fields. The company has developed several products, including the MOMENTUM imager, a pre-clinical MPI solution that produces high-quality images through advanced magnet geometry and a proprietary reconstruction process. Additionally, Magnetic Insight offers VivoTrax, a nanoparticle designed for cell tracking and as a blood pool agent in pre-clinical studies, and Hyper, an add-on module for the MOMENTUM system that assists in identifying treatment targets and administering localized magnetic hyperthermia. Another product, Relax, serves as a particle relaxometry module. Founded in 2012 and headquartered in Alameda, California, Magnetic Insight aims to enhance preclinical diagnostic research by enabling quantitative cell tracking, imaging of vascular functions, and visualization of various biological processes, thereby addressing challenges in clinical and translational research.

Nanochon is focused on creating innovative implantable medical devices designed to address cartilage damage in joints. Utilizing advanced 3D printing techniques and a unique nanomaterial, the company aims to develop solutions that not only replace lost and damaged cartilage but also promote the growth of new tissue. This approach allows medical practitioners to access cost-effective and on-demand devices that enhance treatment outcomes, particularly for young and active patients suffering from knee injuries and diseases. Through its technology, Nanochon seeks to improve the overall quality of care in orthopedics.

Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company founded in 2017 that specializes in developing and commercializing a wearable microfluidic sensing platform. This innovative technology analyzes small droplets of sweat directly from the skin to provide insights into health, hydration, and athletic performance. The platform is designed to measure various biomarkers, including proteomics and inflammatory markers, allowing for personalized management of health and nutrition. Epicore's approach leverages over two decades of research in microfluidics and soft materials conducted by leading experts at Northwestern University. By offering a non-invasive and cost-effective solution, Epicore aims to enhance athletic performance and improve overall health monitoring for users.

Earli is a company focused on developing innovative cancer treatment devices that utilize synthetic biomarkers for early cancer detection. The company's approach involves a novel gene therapy technique known as Synthetic Biopsy, which prompts cancer cells to produce synthetic, non-human biomarkers. These biomarkers can be detected through various means, including blood, urine, or breath, allowing for timely tracking and treatment of cancer. By facilitating the early identification of cancer when it is still homogeneous, Earli aims to significantly enhance survival rates. Their technology not only aids in detection but is also applicable for therapeutic interventions, thereby personalizing treatment and improving patient outcomes.

CytoVale, Inc. is a medical technology company based in San Francisco, California, established in 2012. The company specializes in developing biomarkers that leverage the mechanical properties of individual cells, a field known as mechanomics. By utilizing microfluidics technology, CytoVale can efficiently route and physically probe single cells to measure multiple biomarkers simultaneously. This innovative approach aims to enhance early detection of immune-mediated diseases, particularly sepsis, thereby improving patient outcomes and reducing treatment costs. CytoVale's integration of cell mechanics with machine learning positions it at the forefront of revolutionizing diagnostic practices in healthcare.

TFC Therapeutics is a biotechnology company focused on developing innovative biologics aimed at addressing key drivers of cancer recurrence and metastasis. The company’s technology utilizes monoclonal antibodies that specifically bind to receptors on the surface of tumor-initiating cells (TMH cells). This binding action activates the immune system to target and destroy these cells, offering the potential for new cancer treatments. By concentrating on the elimination of TMH cells, TFC Therapeutics seeks to provide effective solutions for improving patient outcomes in cancer care.

VenoStent, Inc. is a clinical-stage tissue engineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Founded in 2017, it specializes in the development of bioresorbable smart polymers designed to enhance vascular surgery outcomes. The company’s primary product, SelfWrap, is a perivascular wrap that functions as an external stent, providing mechanical support to veins and promoting outward growth. This innovative technology aims to reduce complications at the vein-artery junction in dialysis patients, particularly by minimizing vein collapse and improving the usability of arteriovenous fistulas (AVF). By utilizing a new class of shape-memory polymers that do not require sutures, VenoStent's approach reduces surgery time and lowers the risk of infection, ultimately enhancing the quality and length of life for patients with chronic kidney disease undergoing hemodialysis.

Ossium Health, Inc. is engaged in the development and manufacturing of cell therapy products aimed at treating leukemia, other blood cancers, and tissue damage, as well as addressing radiation poisoning. The company offers a range of innovative therapies, including HPC, Marrow, which features HLA-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients; Chimera, which enhances organ transplantation; and Chymalis, composed of mesenchymal stem cells that promote the healing of damaged bone and muscle tissue. Additionally, Ossium provides bone marrow cells for research purposes in oncology and immunology. Founded in 2016 and headquartered in San Francisco, California, Ossium Health focuses on improving health outcomes and longevity through advanced bioengineering techniques.

MedScout is a revenue acceleration platform tailored for medical device and diagnostic companies. It offers sales enablement software that integrates medical claims intelligence from both public and private payors, providing users with critical insights into market dynamics. The platform is designed to assist sales professionals and leaders by delivering data on patient demographics, procedure volumes, referral patterns, and payment information. This functionality allows clients to conduct thorough market analysis, develop effective strategies, and enhance sales execution, ultimately optimizing operational productivity and fostering growth in their respective territories.

Ascent Integrated Tech develops a hardware-enabled software platform focused on enhancing situational awareness for first responders and military personnel. Its Tactical Assault Kit (TAK) integrates with smartwatches and existing equipment to provide real-time location tracking and physiological alerting, significantly improving safety and operational decision-making during emergencies. The platform offers comprehensive monitoring and mapping capabilities in hazardous environments, enabling incident commanders to assess the status of their teams and make informed evacuation decisions through a biometric tracking system. Ascent’s technology is utilized by major metropolitan fire departments across the United States and is expanding internationally through strategic partnerships. The company is supported by government contracts and venture funding, positioning itself as a leader in redefining emergency response effectiveness.

MEND is a life sciences company dedicated to advancing health and recovery through targeted clinical nutrition and medical food interventions. The company focuses on researching and developing products that enhance patient outcomes in various contexts, including injury recovery, surgical recovery, aging, and physical performance. MEND's solutions have been widely adopted by hospitals, health systems, and professional sports teams across major leagues, as well as by the elite forces of the US Military. Through its commitment to ongoing research and development, MEND aims to empower caregivers and improve health outcomes for individuals facing diverse health challenges.

Portable hospital-grade air purifier developed for Scandinavian hospitals, and trusted by businesses globally

MedCrypt Inc. is a cybersecurity company focused on enhancing the security of medical devices. Founded in 2016 and based in Solana Beach, California, it provides data security solutions tailored for a wide range of medical devices, including pacemakers and surgical robots. MedCrypt's platform allows original equipment manufacturers (OEMs) to easily integrate essential security features, such as user authentication, data encryption, and monitoring for potential malicious activity, into their devices. This capability not only protects sensitive health information but also ensures that devices operate only on commands from trusted sources. By streamlining the implementation of these security measures, MedCrypt enables engineers to prioritize the development of innovative clinical functionalities while maintaining robust protection against unauthorized access and misuse.

Magnetic Insight, Inc. specializes in magnetic particle imaging (MPI), an innovative imaging technology that utilizes iron oxide nanoparticle tracers and time-varying magnetic fields. The company has developed several products, including the MOMENTUM imager, a pre-clinical MPI solution that produces high-quality images through advanced magnet geometry and a proprietary reconstruction process. Additionally, Magnetic Insight offers VivoTrax, a nanoparticle designed for cell tracking and as a blood pool agent in pre-clinical studies, and Hyper, an add-on module for the MOMENTUM system that assists in identifying treatment targets and administering localized magnetic hyperthermia. Another product, Relax, serves as a particle relaxometry module. Founded in 2012 and headquartered in Alameda, California, Magnetic Insight aims to enhance preclinical diagnostic research by enabling quantitative cell tracking, imaging of vascular functions, and visualization of various biological processes, thereby addressing challenges in clinical and translational research.

Miga is a virtual cardiometabolic clinic that combines a character-driven, gamified app (akin to Duolingo) with full-stack clinical services (labs, devices, pharmacy, lifestyle) across obesity, hypertension, diabetes, and hyperlipidemia. Founded by Jarrad Aguirre, MD, and Dre Limberopoulos, Miga is building the future of cardiometabolic health.

Cylera, Inc. is a cybersecurity company focused on protecting healthcare organizations from cyber threats and malware. Founded in 2017 and headquartered in New York, Cylera offers a comprehensive platform that utilizes patented technology to provide unified cybersecurity solutions. Their software specializes in asset management, risk analysis, and threat detection, specifically designed for the healthcare Internet of Things (IoT) environment. By identifying all connected devices, analyzing vulnerabilities, and mitigating threats in real time, Cylera enables healthcare providers and other organizations to effectively manage risks and respond automatically to potential security incidents.

Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company founded in 2017 that specializes in developing and commercializing a wearable microfluidic sensing platform. This innovative technology analyzes small droplets of sweat directly from the skin to provide insights into health, hydration, and athletic performance. The platform is designed to measure various biomarkers, including proteomics and inflammatory markers, allowing for personalized management of health and nutrition. Epicore's approach leverages over two decades of research in microfluidics and soft materials conducted by leading experts at Northwestern University. By offering a non-invasive and cost-effective solution, Epicore aims to enhance athletic performance and improve overall health monitoring for users.

Droplette Inc., founded in 2017 and based in Boston, Massachusetts, specializes in the development of a needle-free skincare device that utilizes a patent-pending transdermal delivery system. This innovative technology allows for the delivery of drugs up to 60% larger than traditional treatments, penetrating deeply into the skin over large surface areas. The device is designed to be painless, contact-free, and portable, generating no disposables. Initially aimed at delivering antibiotics for serious skin conditions such as ulcers and infections, Droplette also envisions future applications for localized delivery of chemotherapeutics for skin cancer and anti-aging treatments. By enabling effective skincare without harmful chemicals, Droplette aims to transform skin health through scientific advancement.

Kinsa is transforming how people care for themselves, their families, and their communities using mobile technologies and products. These same products empower society with tools to track the spread of disease in real-time and stop it. Their first product is a low-cost smartphone-connected thermometer. It allows us to communicate with people who have just fallen ill. It does not simply tell the temperature, rather it transforms the way of caring of the family.

Silvertree is focused on creating innovative wearable technology that caters to the needs of the aging population. The company designs stylish, wrist-worn devices aimed at enhancing safety and fostering connections among active older adults and their families. With a commitment to promoting dignity and independence, Silvertree targets the growing demographic of Americans aged sixty-five and older, which currently numbers around fifty-five million. By prioritizing both functionality and aesthetics, Silvertree positions itself as a leading consumer brand dedicated to the vitality and independence of older individuals.

Leo Cancer Care is focused on revolutionizing cancer radiation therapy by offering a treatment system designed to enhance patient experience and outcomes. Founded in Australia, the company leverages global research that highlights the benefits of upright patient positioning during treatment. This innovative approach shifts the traditional paradigm of machine rotation to patient rotation, allowing for a more controlled and efficient therapy process. The system integrates advanced 3D imaging and precise radiation beam management, ensuring that the appropriate amount of energy is delivered to targeted tissues. By streamlining cancer treatment and connecting patients to centralized care centers, Leo Cancer Care aims to reduce both the physical discomfort and costs typically associated with chemotherapy and radiation therapy, ultimately putting patients in control of their treatment journey.

Moons is a healthcare technology company based in Mexico City that specializes in orthodontic and dental hygiene products. Founded in 2019, the company offers innovative dental services, including the creation of personalized invisible aligners designed for each patient. Customers can visit Moons Studios for an initial consultation, where their teeth are scanned to develop a tailored treatment plan. Moons then manufactures and mails a set of 3D-printed aligners, allowing clients to straighten and whiten their teeth without the use of traditional braces. This process typically enables patients to achieve their desired smile in approximately six months, making orthodontic care more accessible and convenient.

Ascent Integrated Tech develops a hardware-enabled software platform focused on enhancing situational awareness for first responders and military personnel. Its Tactical Assault Kit (TAK) integrates with smartwatches and existing equipment to provide real-time location tracking and physiological alerting, significantly improving safety and operational decision-making during emergencies. The platform offers comprehensive monitoring and mapping capabilities in hazardous environments, enabling incident commanders to assess the status of their teams and make informed evacuation decisions through a biometric tracking system. Ascent’s technology is utilized by major metropolitan fire departments across the United States and is expanding internationally through strategic partnerships. The company is supported by government contracts and venture funding, positioning itself as a leader in redefining emergency response effectiveness.

Shoulder Innovations is a medical device company that has developed inset glenoid fixation technology, creating the most robust and stable glenoid platform in the industry. The company's Total Shoulder Replacement System addresses the most significant issue in shoulder arthroplasty: unreliable fixation of the glenoid implant. It also leverages this technology to create simple surgical instrumentation, which reduces operative time and cost. Shoulder Innovations designs and commercializes innovative products that demonstrate the potential for improved patient care and reduced overall cost to the healthcare system. Published results show Shoulder Innovations’ solution provides greater post-surgical implant stability, addressing the leading cause of revision surgery.

Mission Bio, Inc. is a biotechnology company that specializes in tools for studying cellular heterogeneity in human health and life sciences. The company has developed the Tapestri Platform, the first single-cell multi-omics platform, which allows for the simultaneous analysis of genotype and phenotype from the same cell. This platform utilizes proprietary microfluidic droplet technology to enable precise detection of genomic variability at single-cell resolution, facilitating research in various applications, including oncology, blood cancers, solid tumors, and genome editing. Additionally, Mission Bio offers Tapestri Designer, a cloud-based tool for creating customized single-cell DNA panels, further enhancing its capabilities in targeted molecular analysis. Founded in 2011 and based in South San Francisco, California, the company was previously known as Torrent Bio, Inc. before rebranding in 2013.

Moons is a healthcare technology company based in Mexico City that specializes in orthodontic and dental hygiene products. Founded in 2019, the company offers innovative dental services, including the creation of personalized invisible aligners designed for each patient. Customers can visit Moons Studios for an initial consultation, where their teeth are scanned to develop a tailored treatment plan. Moons then manufactures and mails a set of 3D-printed aligners, allowing clients to straighten and whiten their teeth without the use of traditional braces. This process typically enables patients to achieve their desired smile in approximately six months, making orthodontic care more accessible and convenient.

Asto CT LLC specializes in developing advanced X-ray computed tomography (CT) systems aimed at enhancing equine healthcare. Founded in 2015 and based in Madison, Wisconsin, the company focuses on preventing fractures and improving the overall well-being of thoroughbreds, show horses, recreational horses, and older equines. Asto CT's technology enhances fracture risk detection, facilitates the diagnosis of lameness, and aids in the management of dental and sinus conditions. Their flagship product, Equina, delivers rapid 3D imaging of the lower limbs, head, and neck of standing horses without the need for general anesthesia, ensuring a safer and more comfortable experience for the animals. By integrating cutting-edge robotics with fan-beam CT technology, Asto CT is committed to providing high-quality diagnostic imaging that supports veterinarians in delivering effective treatments.

Excision BioTherapeutics Inc. is a life science company based in Philadelphia, Pennsylvania, established in 2015. The company specializes in developing gene editing therapeutics aimed at treating life-threatening diseases caused by neurotropic viruses. Utilizing CRISPR-based technology, Excision BioTherapeutics focuses on creating advanced gene-editing medicines that can eradicate or disrupt viral genes in human patients. The company is committed to advancing these therapeutics to ensure they are safe and effective, with the goal of significantly improving the lives of individuals affected by viral infections worldwide.

Emme, Inc. is a healthcare technology company based in San Francisco, California, focused on enhancing women's health through innovative solutions. The company has developed the Emme Smart Case and a corresponding mobile application, which together help women manage their birth control more effectively. The smart case employs multi-sensor technology to track when birth control pills are taken, alleviating the stress of remembering to take them and alerting users when back-up contraception is necessary. Additionally, the app provides a comprehensive health overview by allowing users to track their menstrual cycles, mood, and side effects. Founded in 2000, Emme aims to modernize the birth control experience for women, aligning it with contemporary technological advancements.

Notable Labs, Inc. is a clinical-stage company based in Foster City, California, focused on developing personalized testing services for cancer patients, particularly those with brain cancer. The company operates a platform that conducts drug combination experiments on tumors, providing actionable reports to doctors. These reports prioritize combinations of FDA-approved treatments that can be immediately prescribed, avoiding the need for lengthy clinical trials. Notable Labs utilizes its proprietary Predictive Precision Medicines Platform to bio-simulate cancer treatments, predicting patient responses to specific therapies. This approach aims to streamline the identification of patients likely to benefit from targeted treatments, thereby enhancing therapeutic development for cancer care.

She’s Well brings a Netflix-like subscription model to fertility, to help women, men, and couples to have children when they’re ready. The company works with its network of top-tier fertility centers to provide financing plans for fertility testing, IVF, egg freezing and sperm freezing. With an on-demand concierge care approach, She’s Well provides support and guidance, to make the fertility journey less confusing and isolating. 1 in 6 couples has trouble conceiving and we’re waiting longer to try. Women increasingly delay childbirth - one in three women in the U.S. has her first child after 30 and one in ten after 35. Male sperm count has decreased over 50 percent in the last decade. Despite all the solutions available on the market, infertility services remain available to only 1%. Health plans usually don't cover infertility treatments. The typical costs range from 12,000 to 20,000 dollars for IVF, plus another few thousand for the genetic testing involved to ensure the fetus is chromosomally normal. To help, She’s well started out offering subscription plans and concierge guidance to make fertility care more affordable and accessible to the 99%. We need to usher a world where decisions about family and career aren't ruled by biological clocks and where the best options, science, and care are available to everyone who wants to start a family.

Meditrina, Inc. is a medical device company based in San Jose, California, specializing in tissue removal solutions for intrauterine pathology. Founded in 2016, the company has developed the Aveta System, an all-in-one solution designed for hysteroscopic diagnostic and therapeutic procedures. This system enables healthcare professionals to perform tasks such as the removal of polyps and fibroids in both office and operating room settings. The Aveta System features wide-angle HD hysteroscopy with electronic image-lock, advanced fluid management for better pressure and fluid control, and a compact design that allows for seamless integration into various medical environments. By providing advanced, convenient, and cost-effective options, Meditrina aims to enhance the care experience for both patients and physicians.

Vincere Health Inc. is a health technology company based in Allston, Massachusetts, founded in 2019 at the Harvard Innovation Labs. The company has developed a mobile application aimed at assisting users in quitting smoking and making healthier choices through a combination of behavioral nudges, incentives, and evidence-based interventions. Users can set personal health goals and test their adherence by using an attachable breathalyzer device to track their smoking habits daily. The platform offers immediate financial rewards for users who reduce their smoking and ultimately quit. Additionally, Vincere Health provides personalized coaching and real-time progress tracking to support chronic disease management and promote healthier lifestyle choices, addressing significant healthcare challenges primarily focused on smoking cessation.

Mahmee is an integrated care delivery platform focused on improving maternal and infant health. The company aims to address the critical gaps in the U.S. healthcare system, which faces high maternity costs and mortality rates, particularly among Black mothers and infants. By building a digital infrastructure that connects patients, independent health professionals, and healthcare organizations, Mahmee enhances access to comprehensive prenatal and postpartum care. Its platform includes a care management system that links health records for mothers and babies, flags clinical risks, and facilitates collaboration among maternity and infant care practitioners. Additionally, Mahmee’s marketplace allows new and expecting parents to discover care providers and access services both in-person and virtually, thereby supporting better health outcomes for families.

NeuSpera Medical Inc. specializes in the development and manufacturing of ultra-miniaturized implantable devices designed for neuromodulation therapy, focusing on treating chronic illnesses through minimally invasive solutions. The company utilizes its proprietary Mid-Field Powering technology, which harnesses the body as a natural waveguide to direct energy to the implants. This innovative approach allows for external powering of the devices, facilitating deeper and more reliable neuromodulation treatments for conditions such as Urinary Urgency Incontinence (UUI) and chronic peripheral nerve pain. Founded in 2013 and based in San Jose, California, NeuSpera Medical is committed to advancing bioelectronic medicine.

Somna Therapeutics LLC provides medical devices for the treatment of laryngopharyngeal reflux and extraesophageal acid reflux diseases. It offers Reza Band, a non-pharmacologic, investigational esophageal sphincter device that prevents reflux into the larynx, pharynx, and lungs. The company was founded in 2012 and is based in Germantown, Wisconsin.

Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive analytics platform that analyzes the molecular contents of food and ingredients. Its offerings include Clear Dx™ and Clear Safety™, which utilize next-generation sequencing and data analytics for food safety testing and infectious disease surveillance. Clear Labs serves food manufacturers, suppliers, and retailers by ensuring transparency throughout the supply chain and testing products for various factors such as authenticity, contamination, allergens, and nutritional content. The platform delivers actionable insights that enhance safety and operational efficiency while supporting public health initiatives. Through its integrated genomics system, Clear Labs aims to simplify complex diagnostics across clinical and applied markets, making genomic insights accessible to labs, hospitals, and businesses.

Higia Technologies, founded in 2016 and based in Mexico City, develops EVA, a wearable device aimed at assessing breast cancer risk. This non-invasive device features tactile sensors that map the breast's surface and surrounding areas, enabling women to monitor changes in breast temperature, size, and weight. Equipped with biosensors, EVA continuously tracks relevant information, providing users with accessible tools for breast health management.

New Aera, Inc. is a medical device company based in San Ramon, California, founded in 2011. It specializes in developing, manufacturing, and marketing products aimed at individuals suffering from acute respiratory conditions. One of its key offerings is the SideKick TAV, a tidal assist ventilator designed for compatibility with various oxygen sources, including concentrators and cylinders. The company's products focus on enhancing respiratory therapy to alleviate breathlessness and improve exercise endurance, ultimately supporting cardiac patients in achieving better fitness and health. As of August 2019, New Aera operates as a subsidiary of Inogen, Inc.

Emme, Inc. is a healthcare technology company based in San Francisco, California, focused on enhancing women's health through innovative solutions. The company has developed the Emme Smart Case and a corresponding mobile application, which together help women manage their birth control more effectively. The smart case employs multi-sensor technology to track when birth control pills are taken, alleviating the stress of remembering to take them and alerting users when back-up contraception is necessary. Additionally, the app provides a comprehensive health overview by allowing users to track their menstrual cycles, mood, and side effects. Founded in 2000, Emme aims to modernize the birth control experience for women, aligning it with contemporary technological advancements.

Innoblative is developing Sira™, a Saline-assisted Intraoperative Radiofrequency Ablation device that uses bipolar current to intraoperatively create a controlled zone of ablation. Sira’s unique design and saline microinfusion system allow it to have unparalleled contact with target tissue and to be powered with existing electrosurgical generators already installed in the operating room. This device represents an exciting new option for intraoperative ablation of soft tissue which surgeons can easily adopt.

Siris Medical, Inc. is a technology company based in Redwood City, California, that specializes in artificial intelligence-driven decision support systems for radiation therapy in cancer treatment. Founded in 2013, the company has developed the InsightRT Software Suite, which includes tools such as QuickMatch and PlanMD, designed to assist clinicians in managing patient treatment plans effectively. This platform is notable for being the first artificial intelligence decision support system in radiation oncology to receive FDA 510(k) clearance. It employs machine learning to provide real-time insights into treatment plan outcomes, helping clinicians make informed decisions regarding dosage, prescription, and treatment modalities, ultimately aiming to minimize side effects and expedite the initiation of patient treatment. Siris Medical is also affiliated with various innovation incubators, including North Shore InnoVentures and the UCSF / QB3 Rosenman program.

NeuSpera Medical Inc. specializes in the development and manufacturing of ultra-miniaturized implantable devices designed for neuromodulation therapy, focusing on treating chronic illnesses through minimally invasive solutions. The company utilizes its proprietary Mid-Field Powering technology, which harnesses the body as a natural waveguide to direct energy to the implants. This innovative approach allows for external powering of the devices, facilitating deeper and more reliable neuromodulation treatments for conditions such as Urinary Urgency Incontinence (UUI) and chronic peripheral nerve pain. Founded in 2013 and based in San Jose, California, NeuSpera Medical is committed to advancing bioelectronic medicine.

ActiveProtective is a consumer device company that produces smart garments to reduce traumatic injury using wearable airbag technology. The company's proprietary technology uses 3D motion sensors to determine the stereotypical motions and accelerations that govern the body’s normal, daily activities, in order to determine ’departures’ from what is allowable. This technique called "fall disambiguation", allows users to determine falls prior to impact, intercept hip fractures, and protect themselves from risks during sports and military sessions by deploying micro-airbag protection. ActiveProtective was founded in 2006 and is based in Allentown, Pennsylvania.

Center Health builds the future of diabetes with an AI assistant and connected blood sugar meter. Through simple logging and collaboration, personalized insights, and a beautiful experience, Center is here to help you take control and get back to what matters most – living your life.

Celularity is a clinical-stage biotechnology company focused on advancing cellular medicine through the development of off-the-shelf placental-derived allogeneic cell therapies. Its product pipeline includes unmodified and genetically modified natural killer (NK) cells, CAR-engineered T cells, and mesenchymal-like adherent stromal cells. The company targets various health conditions, including cancer, immunologic disorders, infectious diseases, and degenerative illnesses. Celularity leverages the unique biology of the placenta, aiming to create effective and accessible therapies to address significant unmet medical needs. In addition to its cell therapy initiatives, Celularity operates a bio-banking segment, which contributes substantially to its revenue.

Respiratory Motion, Inc. is a medical device company based in Waltham, Massachusetts, that specializes in the development and commercialization of respiratory monitoring devices. Founded in 2011, the company offers the ExSpiron, a point-of-care device designed to non-invasively measure critical respiratory parameters such as minute ventilation, tidal volume, and respiratory rate. With FDA clearance for its continuous monitoring systems, Respiratory Motion provides healthcare professionals with real-time data that enhances patient safety and helps in the early detection of respiratory collapse across various patient populations and clinical settings.

Innoblative is developing Sira™, a Saline-assisted Intraoperative Radiofrequency Ablation device that uses bipolar current to intraoperatively create a controlled zone of ablation. Sira’s unique design and saline microinfusion system allow it to have unparalleled contact with target tissue and to be powered with existing electrosurgical generators already installed in the operating room. This device represents an exciting new option for intraoperative ablation of soft tissue which surgeons can easily adopt.

Kinsa is transforming how people care for themselves, their families, and their communities using mobile technologies and products. These same products empower society with tools to track the spread of disease in real-time and stop it. Their first product is a low-cost smartphone-connected thermometer. It allows us to communicate with people who have just fallen ill. It does not simply tell the temperature, rather it transforms the way of caring of the family.

Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive analytics platform that analyzes the molecular contents of food and ingredients. Its offerings include Clear Dx™ and Clear Safety™, which utilize next-generation sequencing and data analytics for food safety testing and infectious disease surveillance. Clear Labs serves food manufacturers, suppliers, and retailers by ensuring transparency throughout the supply chain and testing products for various factors such as authenticity, contamination, allergens, and nutritional content. The platform delivers actionable insights that enhance safety and operational efficiency while supporting public health initiatives. Through its integrated genomics system, Clear Labs aims to simplify complex diagnostics across clinical and applied markets, making genomic insights accessible to labs, hospitals, and businesses.

Pelvalon is a medical device company focused on improving the lives of women affected by fecal incontinence and pelvic floor disorders. The company develops non-surgical therapy devices that do not contain drugs or hormones, providing effective treatment options for accidental bowel leakage. By addressing the specific needs of female pelvic and bowel health, Pelvalon aims to enhance bowel control and overall well-being for its patients.

Whistle is a technology company based in San Francisco that focuses on enhancing the health and longevity of pets. The company develops an on-collar device that allows pet owners to monitor their pets' daily activities, such as walking, playing, and resting. This data provides valuable insights into the pets' behavior and long-term health trends. Whistle also maintains a comprehensive database of pet health information, which contributes to the advancement of preventative care and aids in veterinary medical research. The leadership team comprises individuals passionate about animals and technology, including Ben Jacobs, Steven Eidelman, and Kevin Lloyd.

Whistle is a technology company based in San Francisco that focuses on enhancing the health and longevity of pets. The company develops an on-collar device that allows pet owners to monitor their pets' daily activities, such as walking, playing, and resting. This data provides valuable insights into the pets' behavior and long-term health trends. Whistle also maintains a comprehensive database of pet health information, which contributes to the advancement of preventative care and aids in veterinary medical research. The leadership team comprises individuals passionate about animals and technology, including Ben Jacobs, Steven Eidelman, and Kevin Lloyd.